Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Bezdenezhnykh
Php236 - Quality of Evidence on the Cost-Effectiveness of Drugs Proposed for the Inclusion in the Russian Vital and Essential Drugs List in 2014-2017
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pcn286 - Incremental Cost-Effectiveness Ratio for the Antineoplastic Drugs Approved and Rejected for the Vital and Essential Drugs List in 2017 in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Inclusion of Ipragliflozin Into the Vital and Essential Drugs List: Budget Impact Analysis
Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
Strategies -Based on Evidence- To Rationalize the High Cost Drugs National List in the Dominican Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Uterotonic Drugs for the Prevention of Postpartum Haemorrhage: A Cost-Effectiveness Analysis
PharmacoEconomics - Open
Health Policy
Pharmacology
The World Health Organization's Model List of Essential Drugs Among Nurses and Pharmacists in Zambia
Journal of Managed Care Pharmacy
Evaluation of Antihypertensive Drugs on the Reimbursement List for the Delisting Policy in Korea
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Designing the Free Drugs List in Nepal
MDM Policy and Practice
Health Policy
Public Health
Occupational Health
Environmental
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014 .
Inclusion of TB Diagnostics on the WHO Essential Diagnostics List
International Journal of Tuberculosis and Lung Disease
Medicine
Pulmonary
Infectious Diseases
Respiratory Medicine
